-transparent.png){kind=logo}
A premature male infant with hyaline membrane disease received a 34 ml transfusion of packed erythrocytes from a CPDA1 blood unit on day 2 with no adverse consequences. On day 34 he was given a transfusion, and the platelet count decreased. Intravenous immune globulin therapy was initiated and the platelet count steadily increased. Human leukocyte (HLA) antigen and platelet antibody testing showed that the thrombocytopenia was due to passive transfer of platelet-specific antibody from the blood donor.
Related Publications
C Marzich, and
P L Strohm, and
M Ayas, and
R K Cochran
May 1992,
Blood,
C Marzich, and
P L Strohm, and
M Ayas, and
R K Cochran
May 1987,
British journal of haematology,
C Marzich, and
P L Strohm, and
M Ayas, and
R K Cochran
January 1984,
Sangre,
C Marzich, and
P L Strohm, and
M Ayas, and
R K Cochran
January 2013,
Journal of perinatology : official journal of the California Perinatal Association,
C Marzich, and
P L Strohm, and
M Ayas, and
R K Cochran
July 2013,
Journal of pediatric hematology/oncology,
C Marzich, and
P L Strohm, and
M Ayas, and
R K Cochran
January 1981,
Transfusion,
C Marzich, and
P L Strohm, and
M Ayas, and
R K Cochran
April 2010,
Acta paediatrica (Oslo, Norway : 1992),
C Marzich, and
P L Strohm, and
M Ayas, and
R K Cochran
January 1999,
Immunohematology,
C Marzich, and
P L Strohm, and
M Ayas, and
R K Cochran
January 1992,
[Rinsho ketsueki] The Japanese journal of clinical hematology,
C Marzich, and
P L Strohm, and
M Ayas, and
R K Cochran
April 1990,
Geburtshilfe und Frauenheilkunde,
